Directorate Change
22 July 2021 07:00 BST Non-Executive Board appointment AstraZeneca PLC announced today that the Board has appointed Andreas Rummelt as a Non-Executive Director, following the completion yesterday of its acquisition of Alexion Pharmaceuticals, Inc. Dr. Rummelt has been a member of the Board of Alexion since 2010. His effective date of appointment to AstraZeneca's Board is 1 August 2021, the same as that of AstraZeneca's new Executive Director and Chief Financial Officer, Dr. Aradhana Sarin (formerly Executive Vice-President, Chief Financial Officer of Alexion), as previously